` ANN (Ansell Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ANN
vs
S&P/ASX 300

Over the past 12 months, ANN has significantly outperformed S&P/ASX 300, delivering a return of 36% compared to the S&P/ASX 300's 11% growth.

Stocks Performance
ANN vs S&P/ASX 300

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ANN vs S&P/ASX 300

Loading
ANN
S&P/ASX 300
Difference

Performance By Year
ANN vs S&P/ASX 300

Loading
ANN
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Ansell Ltd vs Peers

S&P/ASX 300
ANN
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Ansell Ltd
Glance View

Economic Moat
None
Market Cap
4.9B AUD
Industry
Health Care

Ansell Ltd, with its origins tracing back to the innovative entrepreneurship of founder Eric Norman Ansell in the early 20th century, has established itself as a global leader in protection solutions. Initially starting with condoms and expanding into gloves, the company now boasts a diversified portfolio encompassing protective solutions for industrial workers and healthcare professionals. This growth reflects Ansell's adept ability to identify and respond to evolving market demands. The company has capitalized on its deep expertise in material science and product design, underpinning its operations with a robust research and development framework that continually pushes the boundaries of product efficacy and safety. Instrumental to its business model is Ansell’s alignment with regulatory standards across its wide geographical footprint, ensuring that its products not only meet but often exceed industry and safety specifications. By navigating complex regulations and maintaining high standards, Ansell has cemented relationships with a broad clientele base drawn from healthcare providers, industrial entities, and retail channels. The company thrives by leveraging its extensive distribution network and strategic acquisitions, enhancing its global presence. Through innovative product lines, such as cut-protection gloves and surgical solutions, Ansell generates revenue by addressing critical safety needs, ensuring that both individuals and organizations can rely on its products to protect them in the most demanding environments.

ANN Intrinsic Value
40.55 AUD
Undervaluation 17%
Intrinsic Value
Price
Back to Top